| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplastic Cells, Circulating | 60 | 2024 | 938 | 9.080 |
Why?
|
| Microfluidic Analytical Techniques | 60 | 2023 | 806 | 8.570 |
Why?
|
| Cell Separation | 40 | 2024 | 1720 | 6.450 |
Why?
|
| Microfluidics | 36 | 2024 | 652 | 5.360 |
Why?
|
| Cryoprotective Agents | 28 | 2024 | 128 | 5.360 |
Why?
|
| Cryopreservation | 42 | 2024 | 717 | 4.980 |
Why?
|
| Trehalose | 33 | 2018 | 88 | 4.550 |
Why?
|
| Lab-On-A-Chip Devices | 10 | 2023 | 432 | 3.080 |
Why?
|
| Ice | 7 | 2022 | 102 | 2.720 |
Why?
|
| Desiccation | 21 | 2014 | 78 | 2.190 |
Why?
|
| Hepatocytes | 31 | 2024 | 1229 | 2.170 |
Why?
|
| Water | 12 | 2019 | 1407 | 1.710 |
Why?
|
| Vitrification | 5 | 2023 | 51 | 1.610 |
Why?
|
| Blood Preservation | 4 | 2023 | 168 | 1.390 |
Why?
|
| Electroporation | 2 | 2024 | 255 | 1.290 |
Why?
|
| Pseudomonas syringae | 3 | 2018 | 30 | 1.290 |
Why?
|
| Freezing | 15 | 2024 | 306 | 1.250 |
Why?
|
| Oocytes | 14 | 2020 | 1165 | 1.250 |
Why?
|
| Polyvinyl Alcohol | 2 | 2018 | 73 | 1.200 |
Why?
|
| Leukocytes | 10 | 2017 | 2026 | 1.140 |
Why?
|
| Particle Size | 12 | 2018 | 1644 | 1.100 |
Why?
|
| Liver, Artificial | 10 | 2008 | 55 | 1.080 |
Why?
|
| Semen Preservation | 10 | 2016 | 35 | 1.040 |
Why?
|
| Blood Cells | 2 | 2017 | 305 | 1.010 |
Why?
|
| Spermatozoa | 14 | 2016 | 631 | 1.010 |
Why?
|
| Microchemistry | 5 | 2014 | 55 | 1.000 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2018 | 435 | 0.990 |
Why?
|
| Alginates | 3 | 2017 | 248 | 0.980 |
Why?
|
| Organ Preservation | 7 | 2024 | 379 | 0.950 |
Why?
|
| Cell Movement | 12 | 2020 | 5206 | 0.950 |
Why?
|
| Glycerol | 8 | 2021 | 276 | 0.930 |
Why?
|
| Polyethylene Glycols | 10 | 2024 | 1189 | 0.910 |
Why?
|
| Erythrocytes | 9 | 2023 | 2415 | 0.910 |
Why?
|
| Equipment Design | 25 | 2020 | 3520 | 0.900 |
Why?
|
| Cell Membrane Permeability | 4 | 2017 | 575 | 0.870 |
Why?
|
| High-Throughput Screening Assays | 3 | 2020 | 944 | 0.870 |
Why?
|
| Capillaries | 2 | 2016 | 744 | 0.820 |
Why?
|
| Cell Survival | 27 | 2024 | 5797 | 0.820 |
Why?
|
| Cell Line, Tumor | 45 | 2022 | 16939 | 0.800 |
Why?
|
| Cell Size | 5 | 2017 | 624 | 0.800 |
Why?
|
| Biomedical Engineering | 4 | 2018 | 289 | 0.790 |
Why?
|
| Nanotechnology | 5 | 2013 | 709 | 0.740 |
Why?
|
| Neutrophils | 12 | 2017 | 3767 | 0.730 |
Why?
|
| RNA, Neoplasm | 7 | 2020 | 749 | 0.730 |
Why?
|
| Oscillometry | 1 | 2020 | 145 | 0.680 |
Why?
|
| Cell Membrane | 6 | 2024 | 3682 | 0.680 |
Why?
|
| Models, Chemical | 4 | 2009 | 614 | 0.680 |
Why?
|
| Cell Culture Techniques | 13 | 2014 | 1664 | 0.660 |
Why?
|
| Flow Cytometry | 11 | 2017 | 5870 | 0.650 |
Why?
|
| Blood Platelets | 3 | 2020 | 2520 | 0.640 |
Why?
|
| Cumulus Cells | 1 | 2018 | 22 | 0.640 |
Why?
|
| Dehydration | 5 | 2011 | 216 | 0.630 |
Why?
|
| Cell Aggregation | 3 | 2016 | 239 | 0.620 |
Why?
|
| Microarray Analysis | 4 | 2009 | 747 | 0.620 |
Why?
|
| Quartz | 2 | 2008 | 23 | 0.610 |
Why?
|
| Dimethylpolysiloxanes | 6 | 2023 | 142 | 0.610 |
Why?
|
| Temperature | 17 | 2015 | 2221 | 0.600 |
Why?
|
| Animals | 123 | 2024 | 167963 | 0.600 |
Why?
|
| Cold Temperature | 7 | 2024 | 780 | 0.590 |
Why?
|
| Organ Preservation Solutions | 4 | 2024 | 100 | 0.580 |
Why?
|
| Oocyte Retrieval | 1 | 2018 | 158 | 0.580 |
Why?
|
| Blood Specimen Collection | 1 | 2018 | 238 | 0.560 |
Why?
|
| Rats | 35 | 2024 | 23711 | 0.560 |
Why?
|
| Deuterium Oxide | 1 | 2016 | 34 | 0.560 |
Why?
|
| Tissue Engineering | 16 | 2011 | 1870 | 0.550 |
Why?
|
| Single-Cell Analysis | 10 | 2020 | 2380 | 0.550 |
Why?
|
| Surface Properties | 13 | 2017 | 1161 | 0.550 |
Why?
|
| Membranes, Artificial | 3 | 2008 | 367 | 0.550 |
Why?
|
| Oils | 1 | 2016 | 56 | 0.540 |
Why?
|
| Ficoll | 1 | 2016 | 39 | 0.540 |
Why?
|
| Cell Adhesion | 13 | 2020 | 3094 | 0.530 |
Why?
|
| Preservation, Biological | 5 | 2011 | 26 | 0.520 |
Why?
|
| Chemotactic Factors | 2 | 2009 | 196 | 0.510 |
Why?
|
| Exosomes | 2 | 2018 | 424 | 0.510 |
Why?
|
| Electromagnetic Phenomena | 1 | 2016 | 161 | 0.500 |
Why?
|
| Cells, Cultured | 22 | 2024 | 18957 | 0.500 |
Why?
|
| Liver | 11 | 2024 | 7509 | 0.490 |
Why?
|
| Artemia | 3 | 2012 | 6 | 0.490 |
Why?
|
| Burns | 9 | 2010 | 1866 | 0.490 |
Why?
|
| Immunoassay | 3 | 2020 | 746 | 0.480 |
Why?
|
| CHO Cells | 3 | 2011 | 1389 | 0.480 |
Why?
|
| Breast Neoplasms | 23 | 2023 | 21025 | 0.470 |
Why?
|
| Hydrodynamics | 2 | 2019 | 167 | 0.470 |
Why?
|
| Insect Proteins | 2 | 2014 | 254 | 0.460 |
Why?
|
| Blood Component Removal | 2 | 2024 | 132 | 0.460 |
Why?
|
| Coculture Techniques | 11 | 2023 | 1342 | 0.450 |
Why?
|
| Perfusion | 6 | 2022 | 1376 | 0.450 |
Why?
|
| Humans | 173 | 2024 | 760621 | 0.450 |
Why?
|
| Neoplasm Metastasis | 13 | 2022 | 4902 | 0.450 |
Why?
|
| CD4 Lymphocyte Count | 4 | 2009 | 2569 | 0.450 |
Why?
|
| Hydrogels | 8 | 2021 | 723 | 0.450 |
Why?
|
| Leukapheresis | 2 | 2020 | 134 | 0.430 |
Why?
|
| Microspheres | 3 | 2014 | 787 | 0.430 |
Why?
|
| Nanopores | 1 | 2013 | 44 | 0.430 |
Why?
|
| Proteins | 5 | 2024 | 6029 | 0.420 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2014 | 237 | 0.420 |
Why?
|
| Magnetics | 3 | 2013 | 600 | 0.410 |
Why?
|
| Crystallization | 4 | 2018 | 533 | 0.410 |
Why?
|
| Fibroblasts | 8 | 2019 | 4090 | 0.410 |
Why?
|
| 3-O-Methylglucose | 3 | 2016 | 37 | 0.410 |
Why?
|
| RNA | 9 | 2021 | 2722 | 0.410 |
Why?
|
| Sperm Injections, Intracytoplasmic | 7 | 2018 | 156 | 0.400 |
Why?
|
| Receptors, Androgen | 6 | 2024 | 1077 | 0.400 |
Why?
|
| Staphylococcus aureus | 2 | 2018 | 1462 | 0.400 |
Why?
|
| Models, Theoretical | 5 | 2018 | 3562 | 0.400 |
Why?
|
| Glass | 3 | 2008 | 115 | 0.400 |
Why?
|
| Diptera | 1 | 2011 | 50 | 0.390 |
Why?
|
| Rats, Inbred Lew | 12 | 2010 | 1154 | 0.380 |
Why?
|
| Stromal Cells | 4 | 2019 | 1326 | 0.380 |
Why?
|
| Models, Biological | 10 | 2020 | 9467 | 0.380 |
Why?
|
| Biopolymers | 1 | 2012 | 184 | 0.380 |
Why?
|
| Micromanipulation | 2 | 2016 | 52 | 0.380 |
Why?
|
| Cell Tracking | 1 | 2012 | 138 | 0.370 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2010 | 663 | 0.360 |
Why?
|
| Epithelial-Mesenchymal Transition | 7 | 2022 | 730 | 0.360 |
Why?
|
| Tissue Preservation | 3 | 2012 | 174 | 0.360 |
Why?
|
| Nanostructures | 3 | 2015 | 547 | 0.360 |
Why?
|
| Filtration | 2 | 2008 | 229 | 0.350 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2011 | 440 | 0.350 |
Why?
|
| Mice | 62 | 2023 | 81208 | 0.340 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 978 | 0.340 |
Why?
|
| Blood | 2 | 2019 | 586 | 0.340 |
Why?
|
| Antigens, Neoplasm | 2 | 2018 | 1998 | 0.340 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2009 | 13 | 0.330 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2009 | 110 | 0.330 |
Why?
|
| Lymphocytes | 4 | 2006 | 2611 | 0.330 |
Why?
|
| Biocompatible Materials | 6 | 2018 | 1689 | 0.330 |
Why?
|
| Porosity | 4 | 2012 | 349 | 0.330 |
Why?
|
| Point-of-Care Systems | 5 | 2022 | 1204 | 0.330 |
Why?
|
| Neoplasms | 10 | 2020 | 22072 | 0.330 |
Why?
|
| Cells | 2 | 2014 | 164 | 0.330 |
Why?
|
| Mammals | 4 | 2024 | 1131 | 0.320 |
Why?
|
| Computer Simulation | 5 | 2018 | 6218 | 0.320 |
Why?
|
| Microchip Analytical Procedures | 2 | 2023 | 29 | 0.320 |
Why?
|
| Embryonic Stem Cells | 4 | 2008 | 1262 | 0.320 |
Why?
|
| Nanoparticles | 2 | 2011 | 1943 | 0.320 |
Why?
|
| Freeze Drying | 3 | 2018 | 101 | 0.320 |
Why?
|
| Permeability | 4 | 2013 | 719 | 0.320 |
Why?
|
| Antifreeze Proteins | 2 | 2018 | 12 | 0.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2021 | 8515 | 0.310 |
Why?
|
| Fractionation, Field Flow | 1 | 2007 | 3 | 0.310 |
Why?
|
| Sequence Analysis, RNA | 10 | 2020 | 2005 | 0.310 |
Why?
|
| Entrepreneurship | 1 | 2008 | 23 | 0.300 |
Why?
|
| Flow Injection Analysis | 1 | 2007 | 21 | 0.300 |
Why?
|
| Gene Expression Profiling | 11 | 2017 | 9411 | 0.300 |
Why?
|
| Motion | 2 | 2008 | 779 | 0.300 |
Why?
|
| Embryo, Nonmammalian | 1 | 2011 | 900 | 0.290 |
Why?
|
| Keratinocytes | 3 | 2006 | 792 | 0.290 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 551 | 0.290 |
Why?
|
| Prostatic Neoplasms | 12 | 2023 | 11345 | 0.280 |
Why?
|
| Insulin | 5 | 2024 | 6597 | 0.280 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2008 | 330 | 0.280 |
Why?
|
| Sperm Motility | 4 | 2016 | 265 | 0.280 |
Why?
|
| Blastocyst | 7 | 2020 | 433 | 0.280 |
Why?
|
| Video Recording | 1 | 2012 | 955 | 0.280 |
Why?
|
| Time Factors | 27 | 2019 | 40165 | 0.270 |
Why?
|
| Polymethacrylic Acids | 1 | 2006 | 32 | 0.270 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 494 | 0.270 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2010 | 3775 | 0.270 |
Why?
|
| Micropore Filters | 1 | 2005 | 22 | 0.260 |
Why?
|
| Biomedical Technology | 2 | 2007 | 211 | 0.260 |
Why?
|
| Cell Count | 7 | 2022 | 1835 | 0.260 |
Why?
|
| Specimen Handling | 4 | 2021 | 707 | 0.260 |
Why?
|
| Cell Line | 15 | 2017 | 15620 | 0.250 |
Why?
|
| Intracellular Membranes | 2 | 2005 | 389 | 0.250 |
Why?
|
| Antibodies, Immobilized | 2 | 2018 | 23 | 0.250 |
Why?
|
| Medicine | 1 | 2013 | 943 | 0.250 |
Why?
|
| Laser Scanning Cytometry | 1 | 2004 | 5 | 0.250 |
Why?
|
| Mitochondria, Liver | 1 | 2005 | 190 | 0.240 |
Why?
|
| Antibodies | 4 | 2016 | 2421 | 0.240 |
Why?
|
| Eukaryotic Cells | 1 | 2006 | 196 | 0.240 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 151 | 0.240 |
Why?
|
| Sucrose | 4 | 2016 | 156 | 0.240 |
Why?
|
| Liver Failure | 2 | 2004 | 249 | 0.240 |
Why?
|
| HIV Seropositivity | 2 | 2007 | 955 | 0.230 |
Why?
|
| Epithelial Cells | 5 | 2018 | 3663 | 0.230 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 2 | 2021 | 67 | 0.230 |
Why?
|
| Fructose | 1 | 2006 | 287 | 0.230 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2011 | 749 | 0.230 |
Why?
|
| Thrombosis | 1 | 2018 | 3052 | 0.230 |
Why?
|
| Kinetics | 8 | 2012 | 6377 | 0.230 |
Why?
|
| Cell Proliferation | 11 | 2021 | 10446 | 0.230 |
Why?
|
| Carbohydrates | 2 | 2005 | 388 | 0.220 |
Why?
|
| 3T3 Cells | 7 | 2010 | 1085 | 0.220 |
Why?
|
| Shear Strength | 3 | 2014 | 161 | 0.220 |
Why?
|
| Stress, Mechanical | 4 | 2015 | 1666 | 0.220 |
Why?
|
| Cricetinae | 3 | 2011 | 2427 | 0.220 |
Why?
|
| Rheology | 3 | 2012 | 348 | 0.220 |
Why?
|
| Cryptosporidium parvum | 1 | 2023 | 35 | 0.220 |
Why?
|
| Radium | 1 | 2024 | 72 | 0.220 |
Why?
|
| Centrifugation | 2 | 2015 | 122 | 0.220 |
Why?
|
| Cryptosporidium | 1 | 2023 | 41 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 5 | 2022 | 5351 | 0.220 |
Why?
|
| Interleukin-8 | 2 | 2005 | 698 | 0.220 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2024 | 412 | 0.220 |
Why?
|
| Hemolysin Proteins | 1 | 2003 | 114 | 0.210 |
Why?
|
| Muscular Atrophy | 1 | 2006 | 331 | 0.210 |
Why?
|
| Cryptosporidiosis | 1 | 2023 | 53 | 0.210 |
Why?
|
| Emulsions | 2 | 2016 | 152 | 0.210 |
Why?
|
| Hindlimb | 2 | 2024 | 510 | 0.210 |
Why?
|
| Female | 71 | 2023 | 391270 | 0.210 |
Why?
|
| Biological Assay | 2 | 2023 | 630 | 0.210 |
Why?
|
| Hemolysis | 1 | 2004 | 423 | 0.210 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2003 | 352 | 0.210 |
Why?
|
| Nitrogen | 5 | 2011 | 350 | 0.210 |
Why?
|
| Commerce | 1 | 2008 | 605 | 0.200 |
Why?
|
| Heat-Shock Response | 3 | 2009 | 179 | 0.200 |
Why?
|
| Thermodynamics | 4 | 2009 | 599 | 0.200 |
Why?
|
| Protein Array Analysis | 1 | 2004 | 401 | 0.200 |
Why?
|
| Dextrans | 1 | 2004 | 574 | 0.200 |
Why?
|
| Monocytes | 2 | 2009 | 2575 | 0.200 |
Why?
|
| Culture Media | 5 | 2021 | 900 | 0.200 |
Why?
|
| Models, Animal | 4 | 2019 | 2117 | 0.200 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2012 | 1634 | 0.200 |
Why?
|
| Equipment and Supplies | 1 | 2004 | 275 | 0.200 |
Why?
|
| Phase Transition | 4 | 2019 | 71 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 6 | 2021 | 6131 | 0.200 |
Why?
|
| Clinical Protocols | 1 | 2007 | 1440 | 0.190 |
Why?
|
| Hypoglycemic Agents | 2 | 2006 | 3150 | 0.190 |
Why?
|
| Research | 2 | 2008 | 1974 | 0.190 |
Why?
|
| Male | 64 | 2024 | 359744 | 0.190 |
Why?
|
| Osmosis | 5 | 2010 | 103 | 0.190 |
Why?
|
| Reproducibility of Results | 8 | 2020 | 20080 | 0.190 |
Why?
|
| Microscopy, Fluorescence | 6 | 2015 | 2651 | 0.190 |
Why?
|
| Bioreactors | 5 | 2011 | 244 | 0.190 |
Why?
|
| Fetal Blood | 1 | 2007 | 1343 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2011 | 4353 | 0.180 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 56 | 0.180 |
Why?
|
| Ion Channels | 1 | 2005 | 1043 | 0.180 |
Why?
|
| Silicon | 2 | 2013 | 142 | 0.180 |
Why?
|
| Hydrogen Bonding | 2 | 2018 | 291 | 0.180 |
Why?
|
| Polymers | 6 | 2011 | 1621 | 0.180 |
Why?
|
| Polystyrenes | 2 | 2012 | 104 | 0.180 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4625 | 0.180 |
Why?
|
| Zebrafish | 2 | 2023 | 2997 | 0.180 |
Why?
|
| Larva | 3 | 2023 | 509 | 0.180 |
Why?
|
| HeLa Cells | 3 | 2024 | 3105 | 0.170 |
Why?
|
| Hexuronic Acids | 2 | 2017 | 145 | 0.170 |
Why?
|
| Glucuronic Acid | 2 | 2017 | 150 | 0.170 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 4541 | 0.170 |
Why?
|
| Mice, SCID | 6 | 2022 | 2627 | 0.170 |
Why?
|
| Wnt Proteins | 2 | 2015 | 719 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2020 | 5253 | 0.170 |
Why?
|
| Transferrin | 1 | 2020 | 284 | 0.170 |
Why?
|
| Hep G2 Cells | 3 | 2017 | 389 | 0.170 |
Why?
|
| Protein Engineering | 1 | 2003 | 541 | 0.170 |
Why?
|
| Neoplasm Transplantation | 4 | 2020 | 2014 | 0.170 |
Why?
|
| Plasmodium falciparum | 2 | 2023 | 1742 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2018 | 2299 | 0.170 |
Why?
|
| Cricetulus | 2 | 2011 | 815 | 0.170 |
Why?
|
| Dimethyl Sulfoxide | 3 | 2021 | 252 | 0.160 |
Why?
|
| Blood Cell Count | 3 | 2016 | 397 | 0.160 |
Why?
|
| Microinjections | 5 | 2008 | 321 | 0.160 |
Why?
|
| Candidiasis, Invasive | 1 | 2019 | 23 | 0.160 |
Why?
|
| Erwinia | 1 | 2018 | 21 | 0.160 |
Why?
|
| Hypothermia | 1 | 2020 | 188 | 0.160 |
Why?
|
| Liver Failure, Acute | 3 | 2006 | 181 | 0.160 |
Why?
|
| Lipogenesis | 1 | 2020 | 210 | 0.160 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2024 | 8158 | 0.160 |
Why?
|
| Zinc | 1 | 2003 | 689 | 0.160 |
Why?
|
| HIV-1 | 2 | 2022 | 6849 | 0.160 |
Why?
|
| Cycloparaffins | 1 | 2018 | 12 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2020 | 621 | 0.160 |
Why?
|
| Cytoplasm | 3 | 2020 | 1516 | 0.160 |
Why?
|
| Immediate-Early Proteins | 1 | 2021 | 449 | 0.160 |
Why?
|
| Microscopy, Phase-Contrast | 3 | 2009 | 110 | 0.160 |
Why?
|
| Gene Expression | 4 | 2014 | 7588 | 0.160 |
Why?
|
| Anopheles | 1 | 2020 | 192 | 0.160 |
Why?
|
| Pseudomonas | 1 | 2018 | 123 | 0.160 |
Why?
|
| Biosensing Techniques | 1 | 2005 | 677 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2020 | 2471 | 0.150 |
Why?
|
| HIV Infections | 4 | 2022 | 17165 | 0.150 |
Why?
|
| Mice, Inbred Strains | 7 | 2012 | 1763 | 0.150 |
Why?
|
| Microbiological Techniques | 1 | 2019 | 98 | 0.150 |
Why?
|
| Propylene Glycol | 2 | 2008 | 30 | 0.150 |
Why?
|
| Solutions | 4 | 2009 | 419 | 0.150 |
Why?
|
| Candida | 1 | 2019 | 173 | 0.150 |
Why?
|
| Wound Healing | 3 | 2012 | 2788 | 0.150 |
Why?
|
| Ribosomal Proteins | 1 | 2020 | 363 | 0.150 |
Why?
|
| Computational Biology | 1 | 2009 | 3505 | 0.140 |
Why?
|
| Bacterial Toxins | 1 | 2003 | 931 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2020 | 1724 | 0.140 |
Why?
|
| Viscoelastic Substances | 2 | 2014 | 20 | 0.140 |
Why?
|
| Skin | 4 | 2010 | 4466 | 0.140 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 2754 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2024 | 4264 | 0.140 |
Why?
|
| Urea | 4 | 2009 | 446 | 0.140 |
Why?
|
| Automation, Laboratory | 1 | 2017 | 103 | 0.140 |
Why?
|
| Mechanical Phenomena | 1 | 2018 | 140 | 0.140 |
Why?
|
| Signal Transduction | 13 | 2021 | 23376 | 0.140 |
Why?
|
| Prolactin | 1 | 2019 | 621 | 0.140 |
Why?
|
| Silicon Dioxide | 1 | 2018 | 216 | 0.140 |
Why?
|
| Miniaturization | 4 | 2007 | 153 | 0.140 |
Why?
|
| Apoptosis | 4 | 2024 | 9501 | 0.140 |
Why?
|
| beta-Globins | 1 | 2017 | 108 | 0.130 |
Why?
|
| Cytoskeleton | 4 | 2010 | 1167 | 0.130 |
Why?
|
| Androstenes | 1 | 2018 | 182 | 0.130 |
Why?
|
| Mitosis | 1 | 2021 | 1191 | 0.130 |
Why?
|
| Lung Neoplasms | 7 | 2018 | 13262 | 0.130 |
Why?
|
| Liver Neoplasms | 3 | 2018 | 4319 | 0.130 |
Why?
|
| Regenerative Medicine | 1 | 2019 | 307 | 0.130 |
Why?
|
| Calorimetry, Differential Scanning | 3 | 2008 | 98 | 0.130 |
Why?
|
| Electrolytes | 2 | 2007 | 274 | 0.130 |
Why?
|
| Mice, Inbred NOD | 5 | 2021 | 1837 | 0.130 |
Why?
|
| Megakaryocytes | 1 | 2020 | 565 | 0.130 |
Why?
|
| Microtubules | 3 | 2013 | 1072 | 0.130 |
Why?
|
| Tissue Scaffolds | 3 | 2014 | 928 | 0.130 |
Why?
|
| Stress, Physiological | 3 | 2019 | 1398 | 0.130 |
Why?
|
| Adsorption | 2 | 2013 | 198 | 0.130 |
Why?
|
| BRCA2 Protein | 1 | 2020 | 798 | 0.120 |
Why?
|
| Malaria, Falciparum | 1 | 2023 | 1076 | 0.120 |
Why?
|
| Anti-HIV Agents | 2 | 2022 | 4491 | 0.120 |
Why?
|
| Cell Communication | 3 | 2013 | 1653 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.120 |
Why?
|
| B-Lymphocytes | 3 | 2006 | 4742 | 0.120 |
Why?
|
| Proteomics | 3 | 2022 | 3817 | 0.120 |
Why?
|
| Disaccharides | 1 | 2015 | 170 | 0.120 |
Why?
|
| Hypothermia, Induced | 1 | 2020 | 758 | 0.120 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 673 | 0.120 |
Why?
|
| Extracellular Matrix | 2 | 2014 | 1726 | 0.120 |
Why?
|
| Bone Marrow Cells | 2 | 2019 | 2414 | 0.110 |
Why?
|
| Platelet Activation | 1 | 2017 | 660 | 0.110 |
Why?
|
| DNA, Neoplasm | 2 | 2010 | 1745 | 0.110 |
Why?
|
| Physics | 1 | 2014 | 90 | 0.110 |
Why?
|
| Phenylthiohydantoin | 1 | 2015 | 204 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 2 | 2020 | 1347 | 0.110 |
Why?
|
| Materials Testing | 4 | 2015 | 862 | 0.110 |
Why?
|
| Intracellular Space | 1 | 2014 | 197 | 0.110 |
Why?
|
| Precancerous Conditions | 2 | 2017 | 977 | 0.110 |
Why?
|
| Microtechnology | 2 | 2011 | 70 | 0.110 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 1147 | 0.110 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 724 | 0.110 |
Why?
|
| Embryo Transfer | 7 | 2014 | 522 | 0.110 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2017 | 517 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 8950 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2021 | 3584 | 0.110 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 421 | 0.110 |
Why?
|
| Gold | 1 | 2017 | 484 | 0.110 |
Why?
|
| Cell Differentiation | 7 | 2011 | 11481 | 0.110 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1697 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2014 | 564 | 0.100 |
Why?
|
| Oxygen Isotopes | 1 | 2012 | 43 | 0.100 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2012 | 54 | 0.100 |
Why?
|
| Sensitivity and Specificity | 8 | 2013 | 14660 | 0.100 |
Why?
|
| Metal Nanoparticles | 1 | 2017 | 399 | 0.100 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2016 | 530 | 0.100 |
Why?
|
| Antigens, CD | 4 | 2015 | 4000 | 0.100 |
Why?
|
| Cattle | 5 | 2011 | 3847 | 0.100 |
Why?
|
| Acetylation | 1 | 2015 | 1062 | 0.100 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2012 | 63 | 0.100 |
Why?
|
| Brain Neoplasms | 3 | 2020 | 8986 | 0.100 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2005 | 412 | 0.100 |
Why?
|
| GPI-Linked Proteins | 3 | 2011 | 468 | 0.100 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 783 | 0.100 |
Why?
|
| Liver Transplantation | 4 | 2020 | 2325 | 0.100 |
Why?
|
| Carcinoma, Papillary | 1 | 2017 | 785 | 0.100 |
Why?
|
| Cell Shape | 1 | 2013 | 372 | 0.100 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2011 | 31 | 0.100 |
Why?
|
| Nanotubes, Carbon | 1 | 2012 | 71 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1091 | 0.100 |
Why?
|
| Carbohydrate Sequence | 1 | 2012 | 410 | 0.100 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2013 | 132 | 0.100 |
Why?
|
| Blood Viscosity | 1 | 2012 | 124 | 0.100 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2011 | 160 | 0.100 |
Why?
|
| Cell-Derived Microparticles | 1 | 2013 | 161 | 0.100 |
Why?
|
| Killifishes | 1 | 2011 | 8 | 0.100 |
Why?
|
| Microscopy | 2 | 2023 | 885 | 0.100 |
Why?
|
| Embryonic Development | 7 | 2012 | 716 | 0.090 |
Why?
|
| Stochastic Processes | 2 | 2010 | 354 | 0.090 |
Why?
|
| Plant Proteins | 2 | 2011 | 370 | 0.090 |
Why?
|
| Diffusion | 2 | 2021 | 813 | 0.090 |
Why?
|
| Caenorhabditis | 1 | 2011 | 39 | 0.090 |
Why?
|
| Raffinose | 2 | 2024 | 53 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2013 | 1903 | 0.090 |
Why?
|
| DNA | 5 | 2023 | 7233 | 0.090 |
Why?
|
| Mycobacterium smegmatis | 1 | 2011 | 124 | 0.090 |
Why?
|
| Ischemia | 1 | 2020 | 1893 | 0.090 |
Why?
|
| Glioblastoma | 2 | 2018 | 3484 | 0.090 |
Why?
|
| Cell Extracts | 2 | 2011 | 135 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 15789 | 0.090 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 482 | 0.090 |
Why?
|
| Melanoma | 2 | 2020 | 5697 | 0.090 |
Why?
|
| Live Birth | 1 | 2014 | 512 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2006 | 10181 | 0.090 |
Why?
|
| Biological Transport, Active | 2 | 2012 | 327 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4573 | 0.090 |
Why?
|
| Cell Migration Inhibition | 2 | 2008 | 97 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2019 | 2192 | 0.090 |
Why?
|
| Osmolar Concentration | 3 | 2005 | 660 | 0.090 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2010 | 85 | 0.090 |
Why?
|
| Molecular Structure | 2 | 2012 | 1895 | 0.090 |
Why?
|
| Ribonucleotides | 1 | 2010 | 114 | 0.090 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2012 | 412 | 0.090 |
Why?
|
| Cytoprotection | 2 | 2017 | 200 | 0.090 |
Why?
|
| HL-60 Cells | 2 | 2008 | 363 | 0.090 |
Why?
|
| Nylons | 1 | 2009 | 46 | 0.090 |
Why?
|
| Formamides | 1 | 2009 | 21 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2018 | 1302 | 0.090 |
Why?
|
| Nocodazole | 1 | 2009 | 95 | 0.080 |
Why?
|
| Lasers, Solid-State | 1 | 2012 | 175 | 0.080 |
Why?
|
| Histones | 1 | 2020 | 2583 | 0.080 |
Why?
|
| Organ Transplantation | 1 | 2019 | 1150 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 748 | 0.080 |
Why?
|
| Cell Migration Assays | 1 | 2008 | 21 | 0.080 |
Why?
|
| Soybean Oil | 1 | 2010 | 139 | 0.080 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 695 | 0.080 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2698 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2023 | 4373 | 0.080 |
Why?
|
| Skin Transplantation | 2 | 2006 | 1083 | 0.080 |
Why?
|
| Molecular Sequence Data | 5 | 2013 | 17624 | 0.080 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 487 | 0.080 |
Why?
|
| Bandages | 1 | 2010 | 270 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 1827 | 0.080 |
Why?
|
| Genomics | 2 | 2018 | 5794 | 0.080 |
Why?
|
| Equipment Failure Analysis | 2 | 2008 | 848 | 0.080 |
Why?
|
| Thermal Conductivity | 1 | 2008 | 16 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2015 | 5251 | 0.080 |
Why?
|
| Ascitic Fluid | 1 | 2008 | 189 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2018 | 5434 | 0.080 |
Why?
|
| Serum | 1 | 2009 | 211 | 0.080 |
Why?
|
| Exudates and Transudates | 1 | 2008 | 175 | 0.080 |
Why?
|
| Ethylene Glycol | 1 | 2008 | 31 | 0.080 |
Why?
|
| Biophysical Phenomena | 1 | 2009 | 320 | 0.080 |
Why?
|
| Plasma | 2 | 2021 | 584 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 2 | 2011 | 1602 | 0.080 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2006 | 298 | 0.080 |
Why?
|
| Hot Temperature | 3 | 2010 | 1435 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2018 | 2532 | 0.080 |
Why?
|
| Iron Chelating Agents | 1 | 2009 | 138 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2017 | 12766 | 0.080 |
Why?
|
| Ectoderm | 1 | 2008 | 137 | 0.080 |
Why?
|
| Mitochondria | 2 | 2013 | 3600 | 0.070 |
Why?
|
| Melanoma, Experimental | 2 | 2014 | 562 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2011 | 367 | 0.070 |
Why?
|
| Biological Transport | 2 | 2018 | 2086 | 0.070 |
Why?
|
| Cadherins | 3 | 2022 | 898 | 0.070 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 160 | 0.070 |
Why?
|
| Plastics | 1 | 2008 | 115 | 0.070 |
Why?
|
| Fermentation | 1 | 2008 | 146 | 0.070 |
Why?
|
| Hemorheology | 1 | 2007 | 144 | 0.070 |
Why?
|
| Prostate | 2 | 2015 | 1793 | 0.070 |
Why?
|
| Chemotaxis | 2 | 2012 | 598 | 0.070 |
Why?
|
| Connexin 43 | 1 | 2008 | 200 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2008 | 223 | 0.070 |
Why?
|
| Genotype | 5 | 2021 | 12960 | 0.070 |
Why?
|
| Lymphocyte Subsets | 2 | 2005 | 310 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2018 | 22053 | 0.070 |
Why?
|
| Disease Models, Animal | 7 | 2023 | 18137 | 0.070 |
Why?
|
| Germ Layers | 1 | 2007 | 71 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4357 | 0.070 |
Why?
|
| Mitochondrial Proteins | 2 | 2013 | 979 | 0.070 |
Why?
|
| Viscosity | 1 | 2007 | 335 | 0.070 |
Why?
|
| Albumins | 3 | 2005 | 575 | 0.070 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2007 | 51 | 0.070 |
Why?
|
| Organelles | 1 | 2009 | 267 | 0.070 |
Why?
|
| Adenine | 2 | 2020 | 975 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 267 | 0.070 |
Why?
|
| Survival Rate | 3 | 2014 | 12808 | 0.070 |
Why?
|
| Blood Chemical Analysis | 1 | 2008 | 437 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2012 | 2907 | 0.070 |
Why?
|
| Hemoperfusion | 1 | 2006 | 13 | 0.070 |
Why?
|
| Gap Junctions | 1 | 2008 | 230 | 0.070 |
Why?
|
| Cell Lineage | 3 | 2017 | 2533 | 0.070 |
Why?
|
| Molecular Probe Techniques | 1 | 2007 | 117 | 0.070 |
Why?
|
| Androgen Antagonists | 1 | 2015 | 1442 | 0.070 |
Why?
|
| Fluorescent Dyes | 2 | 2012 | 1913 | 0.070 |
Why?
|
| Antioxidants | 2 | 2017 | 1667 | 0.070 |
Why?
|
| Myocardium | 2 | 2011 | 4700 | 0.070 |
Why?
|
| Transfection | 2 | 2011 | 5781 | 0.070 |
Why?
|
| Body Weight | 4 | 2007 | 4611 | 0.070 |
Why?
|
| Rotation | 1 | 2007 | 514 | 0.070 |
Why?
|
| Solubility | 1 | 2007 | 1088 | 0.070 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 2554 | 0.060 |
Why?
|
| Sepsis | 1 | 2020 | 2592 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1095 | 0.060 |
Why?
|
| Skin, Artificial | 1 | 2006 | 89 | 0.060 |
Why?
|
| Swine | 3 | 2024 | 5899 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2006 | 534 | 0.060 |
Why?
|
| Mutation | 9 | 2021 | 29932 | 0.060 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2005 | 86 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 2 | 2003 | 420 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 795 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 5643 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2006 | 315 | 0.060 |
Why?
|
| Avidin | 1 | 2004 | 42 | 0.060 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 453 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2008 | 865 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2020 | 658 | 0.060 |
Why?
|
| Pentanoic Acids | 1 | 2024 | 19 | 0.060 |
Why?
|
| Enterotoxins | 1 | 2006 | 366 | 0.060 |
Why?
|
| Organizational Innovation | 1 | 2008 | 536 | 0.060 |
Why?
|
| Liposomes | 1 | 2008 | 777 | 0.060 |
Why?
|
| Muscle, Skeletal | 3 | 2006 | 4925 | 0.060 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2005 | 159 | 0.060 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2008 | 613 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 995 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2006 | 421 | 0.060 |
Why?
|
| Granulocytes | 1 | 2006 | 551 | 0.060 |
Why?
|
| Microscopy, Atomic Force | 1 | 2004 | 247 | 0.060 |
Why?
|
| Estrogen Receptor alpha | 2 | 2021 | 580 | 0.060 |
Why?
|
| Serum Albumin, Bovine | 1 | 2024 | 323 | 0.060 |
Why?
|
| Swine, Miniature | 1 | 2006 | 959 | 0.060 |
Why?
|
| Basement Membrane | 1 | 2005 | 348 | 0.060 |
Why?
|
| Fertilization in Vitro | 6 | 2009 | 1292 | 0.060 |
Why?
|
| Oocysts | 1 | 2023 | 16 | 0.060 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1529 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 9 | 2014 | 22023 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2020 | 3442 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2011 | 2913 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 11071 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1617 | 0.050 |
Why?
|
| Collagen | 3 | 2014 | 2636 | 0.050 |
Why?
|
| Glucose | 5 | 2016 | 4351 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2014 | 2698 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2009 | 786 | 0.050 |
Why?
|
| Base Sequence | 2 | 2013 | 12446 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2012 | 4219 | 0.050 |
Why?
|
| Neoplastic Processes | 1 | 2022 | 35 | 0.050 |
Why?
|
| Elastic Modulus | 2 | 2016 | 210 | 0.050 |
Why?
|
| Receptors, IgG | 1 | 2006 | 559 | 0.050 |
Why?
|
| Estrogen Antagonists | 1 | 2023 | 151 | 0.050 |
Why?
|
| Allopurinol | 1 | 2024 | 198 | 0.050 |
Why?
|
| Ruthenium | 1 | 2002 | 22 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 2803 | 0.050 |
Why?
|
| Zygote | 1 | 2003 | 115 | 0.050 |
Why?
|
| Mice, Inbred ICR | 2 | 2014 | 364 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2005 | 424 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 1407 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2010 | 1596 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 3202 | 0.050 |
Why?
|
| Insemination, Artificial | 1 | 2002 | 99 | 0.050 |
Why?
|
| Phenotype | 5 | 2016 | 16546 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 13630 | 0.050 |
Why?
|
| Drug Monitoring | 1 | 2008 | 965 | 0.050 |
Why?
|
| Connexins | 1 | 2004 | 351 | 0.050 |
Why?
|
| Calibration | 1 | 2004 | 816 | 0.050 |
Why?
|
| Oxygenators, Membrane | 1 | 2002 | 56 | 0.050 |
Why?
|
| Docosahexaenoic Acids | 1 | 2008 | 912 | 0.050 |
Why?
|
| Phenylacetates | 1 | 2021 | 113 | 0.050 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5201 | 0.050 |
Why?
|
| Tissue Transplantation | 1 | 2002 | 128 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2009 | 1736 | 0.050 |
Why?
|
| Glutathione | 1 | 2024 | 582 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2022 | 3607 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2007 | 2488 | 0.050 |
Why?
|
| Animals, Newborn | 3 | 2014 | 2672 | 0.050 |
Why?
|
| Lysine | 1 | 2006 | 1001 | 0.050 |
Why?
|
| Carbohydrate Metabolism | 1 | 2002 | 262 | 0.050 |
Why?
|
| Oxygen Consumption | 2 | 2007 | 1843 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 3604 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3765 | 0.050 |
Why?
|
| Corticosterone | 1 | 2002 | 304 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 2502 | 0.050 |
Why?
|
| Cornea | 1 | 2009 | 1326 | 0.050 |
Why?
|
| Telemetry | 1 | 2002 | 199 | 0.050 |
Why?
|
| Heart | 2 | 2006 | 4393 | 0.050 |
Why?
|
| Organ Size | 1 | 2006 | 2254 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1334 | 0.050 |
Why?
|
| Cytological Techniques | 1 | 2002 | 218 | 0.040 |
Why?
|
| Deferoxamine | 2 | 2012 | 153 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2014 | 2057 | 0.040 |
Why?
|
| Pregnancy | 7 | 2014 | 29749 | 0.040 |
Why?
|
| HIV | 1 | 2007 | 1579 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 1881 | 0.040 |
Why?
|
| Spleen | 1 | 2006 | 2298 | 0.040 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 1972 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1722 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2011 | 2869 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2006 | 6381 | 0.040 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2019 | 48 | 0.040 |
Why?
|
| Tissue Survival | 1 | 2019 | 119 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2004 | 1982 | 0.040 |
Why?
|
| Cartilage, Articular | 1 | 2006 | 1091 | 0.040 |
Why?
|
| Alanine | 1 | 2022 | 606 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 1993 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2021 | 514 | 0.040 |
Why?
|
| Adenosine | 1 | 2024 | 834 | 0.040 |
Why?
|
| Retinoid X Receptors | 1 | 2019 | 91 | 0.040 |
Why?
|
| Myocytes, Cardiac | 2 | 2011 | 1657 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2020 | 271 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 1674 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2022 | 2864 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 329 | 0.040 |
Why?
|
| Hepatic Stellate Cells | 1 | 2020 | 119 | 0.040 |
Why?
|
| RNA Stability | 1 | 2021 | 333 | 0.040 |
Why?
|
| Oligosaccharides | 2 | 2016 | 405 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 586 | 0.040 |
Why?
|
| Photolysis | 1 | 2018 | 94 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2019 | 4122 | 0.040 |
Why?
|
| Kidney | 2 | 2006 | 7064 | 0.040 |
Why?
|
| Vasodilation | 1 | 2003 | 962 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5799 | 0.040 |
Why?
|
| Polyesters | 2 | 2011 | 372 | 0.040 |
Why?
|
| Stereotaxic Techniques | 1 | 2020 | 549 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 7593 | 0.040 |
Why?
|
| 5'-Nucleotidase | 1 | 2019 | 161 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2006 | 4035 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2019 | 241 | 0.040 |
Why?
|
| Heart Valve Prosthesis | 1 | 2006 | 1495 | 0.040 |
Why?
|
| Research Personnel | 1 | 2002 | 582 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2019 | 350 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2018 | 1529 | 0.040 |
Why?
|
| Phthalazines | 1 | 2020 | 383 | 0.040 |
Why?
|
| Reperfusion Injury | 1 | 2024 | 1023 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 537 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2021 | 704 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 633 | 0.040 |
Why?
|
| Disease Progression | 4 | 2020 | 13502 | 0.040 |
Why?
|
| Adult | 10 | 2022 | 219994 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 4107 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2011 | 941 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2019 | 321 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2002 | 1152 | 0.030 |
Why?
|
| Robotics | 1 | 2004 | 874 | 0.030 |
Why?
|
| Fertilization | 2 | 2009 | 197 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2023 | 1328 | 0.030 |
Why?
|
| Hardness | 1 | 2016 | 35 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 599 | 0.030 |
Why?
|
| Egtazic Acid | 2 | 2007 | 169 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 2018 | 286 | 0.030 |
Why?
|
| U937 Cells | 2 | 2006 | 262 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 3616 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2006 | 2560 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2019 | 598 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2503 | 0.030 |
Why?
|
| Optics and Photonics | 2 | 2008 | 305 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 346 | 0.030 |
Why?
|
| Macrophages | 2 | 2013 | 5745 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 1336 | 0.030 |
Why?
|
| Middle Aged | 11 | 2020 | 220352 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2018 | 2414 | 0.030 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 998 | 0.030 |
Why?
|
| Liver Function Tests | 2 | 2007 | 524 | 0.030 |
Why?
|
| Critical Illness | 1 | 2008 | 2709 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 2210 | 0.030 |
Why?
|
| Osteonectin | 1 | 2014 | 33 | 0.030 |
Why?
|
| gamma Catenin | 1 | 2014 | 44 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6771 | 0.030 |
Why?
|
| Electric Impedance | 2 | 2011 | 755 | 0.030 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3844 | 0.030 |
Why?
|
| Polyamines | 1 | 2015 | 133 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 2014 | 78 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2002 | 1784 | 0.030 |
Why?
|
| Ligands | 2 | 2017 | 3276 | 0.030 |
Why?
|
| Triglycerides | 1 | 2002 | 2476 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 6315 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2002 | 3157 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 1544 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 503 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 3618 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1157 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2002 | 2379 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 26951 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1791 | 0.030 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 495 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 6538 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 10827 | 0.030 |
Why?
|
| Software | 2 | 2010 | 4419 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14372 | 0.030 |
Why?
|
| Indoles | 1 | 2021 | 1829 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6544 | 0.030 |
Why?
|
| Gelatin | 1 | 2015 | 221 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 7408 | 0.030 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2012 | 23 | 0.030 |
Why?
|
| Wnt2 Protein | 1 | 2012 | 28 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 2058 | 0.030 |
Why?
|
| Contact Inhibition | 1 | 2012 | 46 | 0.030 |
Why?
|
| Binding Sites | 1 | 2021 | 6048 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1091 | 0.030 |
Why?
|
| Dynamins | 1 | 2013 | 138 | 0.030 |
Why?
|
| Ki-67 Antigen | 1 | 2014 | 631 | 0.030 |
Why?
|
| Cobalt | 1 | 2012 | 155 | 0.030 |
Why?
|
| Hepatitis B, Chronic | 1 | 2017 | 403 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2024 | 54303 | 0.030 |
Why?
|
| Thienamycins | 1 | 2011 | 29 | 0.030 |
Why?
|
| Adenoviridae | 2 | 2006 | 1084 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 507 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2012 | 5039 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 384 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 532 | 0.020 |
Why?
|
| Genome, Human | 1 | 2005 | 4417 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 717 | 0.020 |
Why?
|
| MADS Domain Proteins | 1 | 2011 | 19 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2004 | 3387 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2011 | 299 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2013 | 277 | 0.020 |
Why?
|
| Morpholines | 1 | 2014 | 583 | 0.020 |
Why?
|
| Decanoates | 1 | 2011 | 55 | 0.020 |
Why?
|
| Metabolomics | 1 | 2020 | 1628 | 0.020 |
Why?
|
| Purines | 1 | 2014 | 605 | 0.020 |
Why?
|
| Aged | 7 | 2020 | 169152 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2019 | 944 | 0.020 |
Why?
|
| Chromatography | 1 | 2011 | 189 | 0.020 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2011 | 103 | 0.020 |
Why?
|
| Cycloserine | 1 | 2011 | 118 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 13981 | 0.020 |
Why?
|
| Droughts | 1 | 2011 | 28 | 0.020 |
Why?
|
| Weight Loss | 1 | 2002 | 2686 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2013 | 301 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 775 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2012 | 256 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 6068 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2015 | 915 | 0.020 |
Why?
|
| Oxygen | 1 | 2002 | 4193 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 370 | 0.020 |
Why?
|
| Bacteriological Techniques | 1 | 2011 | 279 | 0.020 |
Why?
|
| Optical Phenomena | 1 | 2011 | 105 | 0.020 |
Why?
|
| Nitriles | 1 | 2015 | 956 | 0.020 |
Why?
|
| Culture | 1 | 2014 | 622 | 0.020 |
Why?
|
| Sorbitol | 1 | 2010 | 56 | 0.020 |
Why?
|
| Genes, Mitochondrial | 1 | 2010 | 62 | 0.020 |
Why?
|
| Biotinylation | 1 | 2010 | 184 | 0.020 |
Why?
|
| Isoniazid | 1 | 2011 | 283 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 895 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2019 | 2313 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2019 | 2050 | 0.020 |
Why?
|
| Umbilical Cord | 1 | 2011 | 181 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3758 | 0.020 |
Why?
|
| Microcirculation | 1 | 2014 | 1278 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2010 | 137 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 518 | 0.020 |
Why?
|
| Mesoderm | 1 | 2013 | 672 | 0.020 |
Why?
|
| Benzamides | 1 | 2015 | 1369 | 0.020 |
Why?
|
| Logistic Models | 2 | 2017 | 13314 | 0.020 |
Why?
|
| Rifampin | 1 | 2011 | 340 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2015 | 1110 | 0.020 |
Why?
|
| Propylene Glycols | 1 | 2009 | 90 | 0.020 |
Why?
|
| Piperazines | 1 | 2020 | 2525 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 963 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2010 | 285 | 0.020 |
Why?
|
| Cell-Free System | 1 | 2009 | 341 | 0.020 |
Why?
|
| Physical Phenomena | 1 | 2009 | 48 | 0.020 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2008 | 49 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2828 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2009 | 201 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 245 | 0.020 |
Why?
|
| Quinazolines | 1 | 2015 | 1363 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2138 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 566 | 0.020 |
Why?
|
| Biomimetic Materials | 1 | 2010 | 173 | 0.020 |
Why?
|
| Catalase | 1 | 2009 | 216 | 0.020 |
Why?
|
| Electricity | 1 | 2009 | 182 | 0.020 |
Why?
|
| Cell Wall | 1 | 2011 | 425 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2011 | 468 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 670 | 0.020 |
Why?
|
| Gases | 1 | 2009 | 203 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2012 | 1975 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2020 | 2165 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 522 | 0.020 |
Why?
|
| Markov Chains | 1 | 2012 | 968 | 0.020 |
Why?
|
| Homeostasis | 1 | 2019 | 3306 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1115 | 0.020 |
Why?
|
| Systems Biology | 1 | 2012 | 482 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 13451 | 0.020 |
Why?
|
| Litter Size | 1 | 2007 | 49 | 0.020 |
Why?
|
| Prognosis | 3 | 2017 | 29658 | 0.020 |
Why?
|
| Breeding | 1 | 2007 | 51 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 330 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1173 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2008 | 122 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 1077 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 1456 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 58995 | 0.020 |
Why?
|
| Pseudopregnancy | 1 | 2007 | 10 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2011 | 616 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2013 | 770 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 176 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2008 | 622 | 0.020 |
Why?
|
| Aging | 1 | 2006 | 8651 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 751 | 0.020 |
Why?
|
| Sex Ratio | 1 | 2007 | 107 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2014 | 3615 | 0.020 |
Why?
|
| Monitoring, Immunologic | 1 | 2007 | 98 | 0.020 |
Why?
|
| Galactosamine | 1 | 2006 | 27 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 697 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2009 | 591 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2012 | 707 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6216 | 0.020 |
Why?
|
| Research Design | 1 | 2002 | 6180 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2011 | 1608 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2012 | 933 | 0.020 |
Why?
|
| Peritonitis | 1 | 2008 | 369 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2008 | 286 | 0.020 |
Why?
|
| E-Selectin | 1 | 2008 | 576 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 1931 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2012 | 5075 | 0.020 |
Why?
|
| Extracorporeal Circulation | 1 | 2006 | 182 | 0.020 |
Why?
|
| Mercury | 1 | 2008 | 290 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 1436 | 0.020 |
Why?
|
| P-Selectin | 1 | 2008 | 599 | 0.020 |
Why?
|
| Phosphatidylcholines | 1 | 2007 | 406 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 2846 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 365 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 994 | 0.020 |
Why?
|
| Biomimetics | 1 | 2006 | 173 | 0.020 |
Why?
|
| Pregnancy Outcome | 2 | 2007 | 2907 | 0.020 |
Why?
|
| Time | 1 | 2007 | 545 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 1949 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 869 | 0.020 |
Why?
|
| Starfish | 1 | 2004 | 13 | 0.020 |
Why?
|
| Wounds and Injuries | 2 | 2010 | 2477 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 1 | 2006 | 416 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2005 | 143 | 0.020 |
Why?
|
| Response Elements | 1 | 2006 | 308 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 1959 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2005 | 452 | 0.020 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 167 | 0.020 |
Why?
|
| Fibronectins | 1 | 2008 | 722 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2009 | 1089 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2009 | 2176 | 0.010 |
Why?
|
| Transcription Factors | 3 | 2011 | 12103 | 0.010 |
Why?
|
| Fluorescence | 1 | 2007 | 751 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2006 | 674 | 0.010 |
Why?
|
| Cell Division | 1 | 2011 | 4463 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2004 | 106 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2004 | 530 | 0.010 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 2053 | 0.010 |
Why?
|
| Aorta | 1 | 2012 | 2039 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 2006 | 606 | 0.010 |
Why?
|
| Chemokine CXCL12 | 1 | 2006 | 454 | 0.010 |
Why?
|
| ROC Curve | 1 | 2012 | 3568 | 0.010 |
Why?
|
| Receptors, CCR5 | 1 | 2006 | 488 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2009 | 1134 | 0.010 |
Why?
|
| HEPES | 1 | 2003 | 10 | 0.010 |
Why?
|
| Tromethamine | 1 | 2003 | 31 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2018 | 9287 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2011 | 2934 | 0.010 |
Why?
|
| Computer-Aided Design | 1 | 2005 | 302 | 0.010 |
Why?
|
| Noble Gases | 1 | 2002 | 18 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4713 | 0.010 |
Why?
|
| Convection | 1 | 2002 | 30 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2010 | 1738 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2006 | 897 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 397 | 0.010 |
Why?
|
| Proteome | 1 | 2013 | 1855 | 0.010 |
Why?
|
| Buffers | 1 | 2002 | 144 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4490 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 10756 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9276 | 0.010 |
Why?
|
| Meiosis | 1 | 2004 | 328 | 0.010 |
Why?
|
| Body Temperature Regulation | 1 | 1984 | 286 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 201 | 0.010 |
Why?
|
| Fertility | 1 | 2007 | 773 | 0.010 |
Why?
|
| DNA-Binding Proteins | 2 | 2011 | 9585 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 11712 | 0.010 |
Why?
|
| Edetic Acid | 1 | 2002 | 282 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2006 | 1351 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 824 | 0.010 |
Why?
|
| Pregnancy Rate | 1 | 2005 | 649 | 0.010 |
Why?
|
| United States | 2 | 2008 | 72461 | 0.010 |
Why?
|
| Ovum | 1 | 2002 | 187 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2008 | 2608 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 2010 | 9185 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 940 | 0.010 |
Why?
|
| Linear Models | 1 | 2012 | 5877 | 0.010 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2008 | 793 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6238 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2012 | 8313 | 0.010 |
Why?
|
| Physical Exertion | 1 | 1984 | 662 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2014 | 4938 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2006 | 728 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5649 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 2002 | 270 | 0.010 |
Why?
|
| Chromatin | 1 | 2012 | 2938 | 0.010 |
Why?
|
| Lipids | 1 | 2012 | 3336 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15289 | 0.010 |
Why?
|
| HIV Antibodies | 1 | 2007 | 1300 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3735 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2696 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2010 | 2529 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2004 | 1134 | 0.010 |
Why?
|
| Electrodes | 1 | 2002 | 614 | 0.010 |
Why?
|
| Forecasting | 1 | 2009 | 2932 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1984 | 732 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2002 | 928 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2008 | 1387 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 4048 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2006 | 1765 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 2002 | 579 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2282 | 0.010 |
Why?
|
| Cancer Vaccines | 1 | 2006 | 1046 | 0.010 |
Why?
|
| Prostheses and Implants | 1 | 2004 | 1273 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2221 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2006 | 2536 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2006 | 3215 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2005 | 2141 | 0.010 |
Why?
|
| International Cooperation | 1 | 2002 | 1433 | 0.010 |
Why?
|
| Amino Acids | 1 | 2002 | 1714 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2006 | 1454 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 39261 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 65017 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3527 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3517 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 8555 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2002 | 1500 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8552 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20509 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2002 | 1804 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 11152 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2010 | 14495 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 12531 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 9530 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 18416 | 0.010 |
Why?
|
| Patient Selection | 1 | 2005 | 4283 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 5496 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 80372 | 0.010 |
Why?
|
| Internet | 1 | 2002 | 3078 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 25942 | 0.010 |
Why?
|
| Hospitalization | 1 | 2008 | 10790 | 0.000 |
Why?
|
| Infant | 1 | 2010 | 36060 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2010 | 42063 | 0.000 |
Why?
|
| Databases, Factual | 1 | 2002 | 8035 | 0.000 |
Why?
|
| Aerobiosis | 1 | 1984 | 101 | 0.000 |
Why?
|
| Acclimatization | 1 | 1984 | 112 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 58741 | 0.000 |
Why?
|
| Sweating | 1 | 1984 | 154 | 0.000 |
Why?
|
| Child | 1 | 2010 | 79806 | 0.000 |
Why?
|
| Heart Rate | 1 | 1984 | 4179 | 0.000 |
Why?
|